`571-272-7822
`
`
`
` Paper 39
`
`Entered: June 11, 2018
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`____________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`____________
`
`MYLAN PHARMACEUTICALS INC.,
`Petitioner
`
`v.
`
`POZEN INC. and HORIZON PHARMA USA, INC.,
`Patent Owner
`____________
`
`Case IPR2017-01995
`Patent 9,220,698 B2
`____________
`
`
`
`Before TONI R. SCHEINER, MICHELLE N. ANKENBRAND, and
`DEBRA L. DENNETT, Administrative Patent Judges.
`
`DENNETT, Administrative Patent Judge.
`
`
`ORDER
`Granting Petitioner Mylan Pharmaceuticals Inc.’s
`Motion for Pro Hac Vice Admission of Bryan D. Beel and Robert D. Swanson
`37 C.F.R. § 42.10
`
`
`
`
`Case IPR2017-01995
`Patent 9,220,698 B2
`
`
`On April 2, 2018, Petitioner Mylan Pharmaceuticals Inc. (“Mylan”) filed
`Motions for Pro Hac Vice Admission of Bryan D. Beel (Paper 27) and Robert D.
`Swanson (Paper 28) under 37 C.F.R. § 42.10(c). The Motions are supported by the
`Declaration of Mr. Beel (Ex. 1048) and the Declaration of Mr. Swanson (Ex.
`1049).
`The Board has reviewed the submissions and determined that the
`requirements of 37 C.F.R. § 42.10 have been met and there is good cause to admit
`Mr. Beel and Mr. Swanson pro hac vice in the proceeding.
`It is, therefore,
`ORDERED that Mylan’s Motion for Pro Hac Vice Admission of Bryan D.
`Beel under to 37 C.F.R. § 42.10(c) is granted;
`FURTHER ORDERED that Mylan’s Motion for Pro Hac Vice Admission of
`Robert D. Swanson under to 37 C.F.R. § 42.10(c) is granted;
`FURTHER ORDERED that, within seven (7) business days of the date of
`this Order, Mylan must submit a Power of Attorney for Mr. Beel and Mr. Swanson
`in accordance with 37 C.F.R. § 42.10(b);
`FURTHER ORDERED that Mr. Beel and Mr. Swanson are authorized to act
`as back-up counsel only, and that Mylan is to continue to have a registered
`practitioner represent it as lead counsel;
`FURTHER ORDERED that Mylan must file updated mandatory notices
`identifying Mr. Beel and Mr. Swanson as back-up counsel in accordance with
`37 C.F.R. § 42.8(b)(3);
`FURTHER ORDERED that Mr. Beel and Mr. Swanson are to comply with
`the Office Patent Trial Practice Guide and the Board’s Rules of Practice for Trials,
`as set forth in Part 42 of 37 C.F.R.; and
`
`
`
`2
`
`
`
`Case IPR2017-01995
`Patent 9,220,698 B2
`
`
`FURTHER ORDERED that Mr. Beel and Mr. Swanson are to be subject to
`the Office’s disciplinary jurisdiction under 37 C.F.R. § 11.19(a), and the USPTO
`Rules of Professional Conduct set forth in 37 C.F.R. §§ 11.101–11.901.
`
`PETITIONER:
`
`Brandon M. White
`Emily Greb
`PERKINS COIE LLP
`bmwhite@perkinscoie.com
`egreb@perkinscoie.com
`
`
`PATENT OWNER:
`
`Thomas A. Blinka, Ph.D.
`COOLEY LLP
`TBlinka@cooley.com
`Margaret J. Sampson, Ph.D.
`BAKER BOTTS LLP
`Margaret.Sampson@bakerbotts.com
`
`
`
`3
`
`